ABSTRACT
INTRODUCTION
Twin-to-twin transfusion syndrome (TTTS) is the most frequent and severe complication of monochorionic twin pregnancies, affecting approximately 10% 1 . The diagnosis of TTTS is based commonly on a deepest vertical pocket (DVP) of amniotic fluid > 8 cm in the amniotic sac of the recipient twin and a DVP < 2 cm in the donor twin 2 . The mean gestational age at diagnosis is 20 weeks and, if untreated, perinatal mortality is approximately 90% 3 . Current guidelines recommend screening every 2 weeks in all monochorionic diamniotic (MCDA) twin pregnancies in order to detect TTTS [4] [5] [6] . However, not all centers follow such recommendations, and some cases may be missed even within a 2-week interval and others lost due to late diagnosis. Such an approach demands a lot of resources and most MCDA pregnancies (approximately 90%) do not develop TTTS. Therefore, efforts to predict which MCDA twin pregnancies are at increased risk of developing TTTS are warranted. Studies published so far have investigated the predictive ability of first-trimester nuchal translucency (NT), crown-rump length (CRL) and ductus venosus (DV) Doppler flow [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Although an increased NT, intertwin discrepancy in NT or CRL and abnormal DV flow have been reported as early signs of hemodynamic imbalance predisposing to TTTS, published data are not univocal. Other markers, such as amniotic fluid volume discrepancy, membrane folding, arterioarterial placental anastomosis detection by Doppler ultrasound and maternal circulating mRNA levels have also been proposed as predictors of TTTS later in pregnancy [20] [21] [22] [23] [24] [25] [26] [27] . The aim of this systematic review and meta-analysis of the current literature was to assess the role of first-and early second-trimester (prior to 16 weeks' gestation) ultrasound markers in the prediction of TTTS in monochorionic twin pregnancies.
METHODS
This review was conducted according to a protocol with generally accepted methods for diagnostic and screening test accuracy evaluations in systematic reviews and meta-analyses [28] [29] [30] . Given the study design, neither institutional review board approval nor informed consent was required. The study was registered with the Prospective Registering of Systematic Reviews (PROSPERO) database (registration number: CRD42011001192, http:// www.crd.york.ac.uk/PROSPERO).
Search strategy
The electronic databases MEDLINE, EMBASE and ClinicalTrials.gov were searched from inception to 30 April 2014 using combinations of the relevant medical subject heading (MeSH) term 'fetofetal transfusion', and its word variants were searched in combination with the phrases 'predictive value', 'sensitivity', 'specificity', 'false positive', 'false negative', 'screening', 'accuracy' and 'ROC', according to published guidelines 28 (Table S1 ). In addition, the reference lists of all primary articles and recent articles, editorials and reviews published on the subject were screened to identify those not found by the initial searches.
Study selection
Two trained reviewers (V.S. and C.Z.) screened independently titles and abstracts for relevance. The full text of relevant articles was evaluated independently (V.S. and C.Z.) and agreement about potential eligbility was reached by consensus. Authors of articles in which information required for the meta-analysis was not reported were contacted.
Studies were excluded from the analysis if: the prediction of TTTS was performed after 16 weeks' gestation; the study was published in non-English language; or the study population was included in more than one published study by the same authors. If more than one study was published for the same cohort with identical endpoints, the report containing the most comprehensive population was included to avoid overlapping populations.
Data extraction and quality assessment
Two reviewers (V.S. and C.Z.) assessed the selected studies independently for methodological quality against the quality assessment of diagnostic accuracy studies (QUADAS-2) criteria 31 . High risk of bias on QUADAS-2 assessment was not considered an exclusion criterion. Articles were included in the systematic review if all the relevant data were available from the text or provided by the original study authors. A meta-analysis was planned for the following main published predictive factors for TTTS. (1) Intertwin NT discrepancy: in the literature, the most commonly reported cut-off was 20%; otherwise, NT discrepancy was ≥ 0.6 mm or was calculated as the NT percentage of the smaller NT value. (2) NT > 95 th percentile in at least one twin. When individual data were available, NT percentile was adjusted for CRL according to The Fetal Medicine Foundation curves using commercially available software (PIA Fetal Database, GE ViewPoint, Wessling, Germany). (3) Intertwin CRL discrepancy expressed as a percentage of the larger CRL. In the literature, the most commonly reported cut-off was 10%; otherwise, CRL discrepancy was calculated as the CRL ratio or CRL discrepancy > 12 mm. (4) Abnormal DV flow in at least one twin. DV flow was defined as abnormal when reversed A-wave flow was present.
Statistical analysis
The outcome observed was TTTS, defined according to the presence of an oligohydramnios-polyhydramnios sequence. Two-by-two contingency tables were constructed for each possible predictive parameter and each included study. Sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-) and diagnostic odds ratio (DOR) were calculated using the DerSimonian-Laird random-effects model and represented as forest plots. Between-study heterogeneity was analyzed using the I 2 statistic, where values of > 50% indicate a substantial level of variation between all studies. Statistical analysis was performed with Meta-DiSc 1.4 statistical software (http://www.hrc.es/investigacion/metadisc_en.htm). A P-value < 0.05 was considered statistically significant.
LRs are used for assessing the value of performing a diagnostic test. They use the sensitivity and specificity of the test to determine whether a test result usefully changes the probability that a condition (i.e. TTTS) exists and allow interpretation of the results within a clinical context. A LR > 10 for a positive test and < 0.1 for a negative test are considered to provide good predictive evidence. Moderate prediction is generally considered when a test has a LR of 5-10 and 0.1-0.2, whereas those < 5 and > 0.2 offer only minimal prediction. The DOR of a test is the ratio of the odds of positivity in disease relative to the odds of positivity in the non-diseased. The value of DOR ranges from 0 to infinity, with higher values indicating better discriminatory test performance. Since it expresses diagnostic performance as a single term, the DOR is particularly useful when comparing the performance of competing tests.
In order to take into account not only the prespecified cut-off values, but combine information from multiple thresholds, the output was also expressed as a hierarchical summary receiver-operating characteristics (hSROC) curve. The hSROC curve shows the summary trade-off between sensitivity and specificity across the included studies. Given the ability of hSROC to account for the variation in cut-off definition, all the studies exploring the prognostic value of NT discrepancy were included in the meta-analysis, regardless of the cut-off used. A bivariate random-effects model was implemented using Stata software (release 14; StataCorp, College Station, TX, USA), to produce average test sensitivity and specificity, with a 95% CI using the metandi user-written macro; this macro also allows calculation of hSROC curves and the prediction region, and also plots the summary point and its confidence region.
The random-effects model and the hSROC were not performed for the analysis of abnormal DV because of the small number of included studies.
RESULTS
The electronic search yielded 152 records; 23 were confirmed to be relevant for the review after evaluation of the title and abstract. Ten studies were excluded after assessment of the full text as they did not meet the inclusion criteria (Table S2) . Thus, 13 studies were included in the review [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] (Figure 1) , comprising a total of 1991 twin pregnancies, of which 323 developed TTTS. Table 1 provides summary characteristics for all included studies. Eight studies evaluated the intertwin NT discrepancy 7,9-12,14-16 , two of which did not calculate discrepancy as a percentage of the larger NT value but reported instead a NT discrepancy ≥ 0.6 mm 15 and as a percentage of the smaller NT value 16 . Original data were not available for one study 16 , and hence seven studies were included in the meta-analysis for intertwin NT discrepancy. Seven studies evaluated the predictive value of NT thickness > 95 th percentile [7] [8] [9] 12, [17] [18] [19] . In one additional study 14 , this information was derived from the original data, whereas the original data of one study 18 were not available, and hence seven studies were included in the meta-analysis for NT thickness > 95 th percentile. Eight studies evaluated the intertwin CRL discrepancy [7] [8] [9] [10] [11] [12] 15, 16 , two of which did not calculate discrepancy as a percentage of the larger CRL value but as a CRL discrepancy ≥ 10 mm and the CRL ratio 15 and a CRL discrepancy > 12 mm 11 . Original data of one study were not available 15 , and hence seven Records identified through database search and screened by title and abstract (n = 152)
Records excluded because did not meet inclusion criteria (n = 129)
Full-text articles excluded because did not meet inclusion criteria (n = 10)
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Figure 1
Flowchart of identification of studies included in systematic review. QUADAS-2, quality assessment of diagnostic accuracy studies. Proportion of studies with low, high or unclear concerns regarding applicability (%) 60 80 100 Figure 2 Quality assessment for risk of bias (a) and concerns regarding applicability (b) in studies included in systematic review, using quality assessment of diagnostic accuracy studies (QUADAS-2). , low risk; , high risk; , unclear risk. studies were included in the meta-analysis for intertwin CRL discrepancy. Two studies evaluated the predictive value of abnormal DV flow 13, 15 . As only one study evaluated amniotic fluid discrepancy prior to 16 weeks' gestation 11 and one evaluated membrane folding 17 , these two parameters were not considered for the meta-analysis.
QUADAS-2 was used to assess all included studies (Figure 2) . Evaluation of the risk of bias showed a high risk of selection bias in the majority of studies (n = 9, I 2 = 69%) and the description of the index test was unclear in nine (I 2 = 69%). Consequently, the concern about applicability was mostly high as regards patient selection and description of the index test. Moreover, ascertainment of outcome was suspected of bias when the definition of TTTS was investigated (Table 1) ; four studies did not define clearly the oligohydramnios-polyhydramnios sequence, but used instead descriptive terms such as bladder filling and polyhydramnios/oligohydramnios 10, 13, 14, 17 . In the nine studies remaining, two different definitions of oligohydramnios-polyhydramnios sequence were used, including a DVP < 2 cm in the donor twin and > 8 cm in the recipient twin after 16 weeks' gestation, regardless of gestational age 7, 12, 15, 16, 18, 19 , and a DVP < 2 cm and > 8 cm before 20 weeks and < 2 cm and > 10 cm after 20 weeks in the donor and recipient twin, respectively 8, 9, 11 . Two studies excluded patients with TTTS Quintero Stage I 14, 16 . In addition, ultrasound scans were not performed every 2 weeks in most of the studies, as recommended by international guidelines 4, 32 , thus adding another potential ascertainment bias.
Performance of the different first-and early secondtrimester ultrasound parameters in predicting TTTS are given for each study in Table 2 , and the results of the meta-analysis are reported in Table 3 . Fratelli (2011) 9 Kagan (2007) 10 Lewi (2008) 11 Linskens (2009) 12 Matias (2005) 14 Matias (2010) El Kateb (2007) 8 Fratelli (2011) 9 Linskens (2009) 12 Matias (2005) 14 Sebire (2000) 17 Sueters (2006) 
Intertwin NT discrepancy
The accuracy of intertwin NT discrepancy in predicting TTTS was low. This ultrasound parameter had low sensitivity (52.8% (95% CI, 43.8-61.7%)) but relatively good specificity (72.5% (95% CI, 61.7-82.0%)). Between-study heterogeneity was high, especially regarding specificity (I 2 = 48.7% for RR, I 2 = 84.3% for specificity).
NT thickness > 95 th percentile
The accuracy of NT thickness > 95 th percentile in predicting TTTS was very low. This ultrasound parameter had very low sensitivity (22.3% (95% CI, 14.0-33.6%)) but good specificity (91.5% (95% CI, 87.4-94.4%)). There was between-study heterogeneity for specificity (I 2 = 57.6%).
Intertwin CRL discrepancy
The accuracy of intertwin CRL discrepancy > 10% in predicting TTTS was very low. This parameter had a very low sensitivity (15.9% (95% CI, 5.8-36.9%)) but a high specificity (91.1% (95% CI, 83.8-95.3%)). Between-study heterogeneity was generally high, for both sensitivity and specificity (I 2 = 79.4% and 84.1%, respectively).
Reversed DV flow
Reversed DV flow on first-trimester ultrasound examination seems to be the most powerful factor for predicting TTTS. It had a higher sensitivity (50.0% (95% CI, 33.4-66.6%)) when compared with the other predictive parameters. Its specificity was good (87.5% (95% CI, 82.6-91.4%)). However, only two studies analyzed this parameter and between-study heterogeneity was high (I 2 = 78% for sensitivity; I 2 = 61.9% for specificity). Figure 3 shows forest plots for sensitivity and specificity of intertwin NT discrepancy, NT > 95 th percentile, intertwin CRL discrepancy and reversed DV flow in the prediction of TTTS. Sensitivity and specificity of the ultrasound parameters for each study included in the meta-analysis are plotted in Figure 4 . Figure 5 shows the hSROC curves for the capacity of the ultrasound parameters to predict TTTS. Analysis of abnormal DV flow is not represented in Figures 4 and 5 because the small number of studies did not allow this to be performed.
DISCUSSION
In this systematic review, we found that, in monochorionic twin pregnancies, intertwin NT discrepancy, NT > 95 th percentile, intertwin CRL discrepancy and reversed DV flow in the first trimester of pregnancy are associated with the risk of developing severe TTTS later in gestation.
Due to the increased risk of complications, most specifically TTTS, monochorionic twin pregnancies require Figure 5 Hierarchical summary receiver-operating characteristics (hSROC) curves for capacity of intertwin nuchal translucency thickness (NT) discrepancy (a), NT > 95 th percentile (b) and intertwin crown-rump length discrepancy > 10% (c) to predict twin-to-twin transfusion syndrome. , summary point; , study estimate;
, hSROC curve; , 95% confidence region; , 95% prediction region. intensive surveillance. Data from the literature and guidelines [4] [5] [6] 19, [32] [33] [34] suggest that ultrasound examinations should be performed at least every 2 weeks from 16 weeks' gestation to allow early detection of TTTS. However, such an approach is both time-and resource-consuming. Early identification of pregnancies at the highest risk of TTTS would allow improvement of parental counseling and intensify the surveillance in this group, which would possibly lead to a timely transfer to a referral center. Alternatively, it would result in a decrease in the intensity of ultrasound follow-ups in pregnancies considered confidently to be at low risk of TTTS. Altogether, these effects could improve pregnancy and neonatal outcomes, reducing simultaneously the burden on the family and the healthcare system.
It is tempting to embrace the theory that an early hemodynamic imbalance in cases of TTTS may lead to discordance in NT thickness and fetal size, measured by CRL, as well as to abnormalities in DV flow 35 . Our findings support the concept that, at the time of the first-trimester ultrasound scan, when chorionicity can be better determined, additional ultrasound findings, such as intertwin NT discrepancy, NT > 95 th percentile, intertwin CRL discrepancy or reversed DV flow, are associated with an increased likelihood of the subsequent development of severe TTTS. However, their predictive accuracy is insufficient to allow any safe changes to the currently recommended surveillance regimes. In addition, the heterogeneity in diagnostic criteria for TTTS in the studies included in the meta-analysis raises the possibility of a substantial ascertainment bias, increased by the lack of standardized scheduling of follow-up scans. We lacked statistical power to investigate whether the predictive accuracy of the different ultrasound parameters analyzed was affected by the criteria used to diagnose TTTS.
Intertwin CRL discrepancy has been found to be associated with the subsequent development of selective intrauterine growth restriction (sIUGR) in MCDA pregnancies 9, 16 . An explanation of the lower sensitivity for TTTS of intertwin CRL discrepancy compared with intertwin NT discrepancy and abnormal DV flow may be that TTTS is associated with growth restriction of the donor twin in only two-thirds of cases 36 ; in one-third of cases of TTTS without sIUGR, first-trimester CRL discrepancy may have reduced predictive performance.
In our analysis, we were unable to assess the relationship between first-trimester predictors and gestational age at onset of TTTS. TTTS is known to occur after 20 weeks in pregnancies that have been otherwise unremarkable up until that point. Therefore, the factors that result in TTTS may not all be present in the first trimester but may decompensate over time (e.g. structural congenital heart disease) or occur later in pregnancy (e.g. infarct of a placental cotyledon resulting in unbalanced blood sharing between the twins). Thus, our analysis might have better predictive accuracy for early, rather than late, development of TTTS. These considerations may explain the overall limited performance of the tests.
Other ultrasound findings have been reported as possible predictors of severe TTTS. Sebire et al. 20 described the role of folding of the intertwin membrane in a cohort of 83 monochorionic twin pregnancies. In their cohort, membrane folding at 15-17 weeks' gestation detected (moderate and severe) TTTS with a sensitivity of 95% (95% CI, 79-99%) and a specificity of 86% (95% CI, 76-92%). Lewi et al. 11 proposed a formula for TTTS prediction, combining findings at first-and second-trimester ultrasound scan. Discordant amniotic fluid and discordant CRL ≥ 12 mm were considered in the first trimester, while discordance in amniotic fluid, cord insertions and abdominal circumference were evaluated at 16 weeks' gestation. Different combinations of these findings corresponded to a different risk level of developing TTTS. Moreover, the authors concluded that a more than 50% chance of complicated outcome was associated with the presence of discordant amniotic fluid and cord insertions (defined as the combination of a velamentous cord insertion in one twin, together with eccentric cord insertion in the other). Recently, Costa-Castro et al. 37 did not confirm the association between velamentous cord insertion and TTTS, even though it seemed to correlate generally with a poorer outcome.
This meta-analysis was performed with data obtained from the original articles or provided by authors of the articles. Nevertheless, some articles could not be included.
Moreover, the authors chose different cut-offs to evaluate the association of the ultrasound parameter with TTTS. In order to reduce the bias associated with prespecified cut-off values, we combined information from multiple thresholds, performing an hSROC curve analysis.
In conclusion, this meta-analysis confirms that an association exists between the subsequent development of TTTS and intertwin NT discrepancy, NT > 95 th percentile, intertwin CRL discrepancy and reversed DV flow at the time of the first-trimester ultrasound scan.
